Latest News
Keep up to date with the latest news and announcements from Theragnostics
Theragnostics Announces US FDA Approval for its Radiodiagnostic Imaging Drug NephroScanTM (Kit for the Preparation of Technetium Tc 99m Succimer Injection)
February 22, 2022Theragnostics Announces that its Radiotherapeutic for Treatment of Glioblastoma Multiforme has been Awarded UK’s MHRA Innovation Passport
February 10, 2022Theragnostics Announces Licensing Agreement for Development and Commercialization of One-Step PET Radiopharmaceuticals
September 22, 2021Theragnostics Strengthens Board of Directors with Key Appointments
August 4, 2021Theragnostics Announces a research collaboration with Essen University Hospital to study THG-008 for Oncology PET Imaging
February 17, 2021Developing radionuclide PARP inhibitors – MedNous Article
November 19, 2020Theragnostics Holding 1-2-1 Meetings at Jefferies 2020 Virtual London Healthcare Conference
November 10, 2020Summit Biomedical Imaging Signs Agreement with Theragnostics Enabling the Development of Novel Fluorescence-Based Cancer Diagnostics
September 9, 2020Theragnostics Collaborate on £6 million MITHRAS Research Programme
June 2, 2020News Archive
Theragnostics Announces US FDA Approval for its Radiodiagnostic Imaging Drug NephroScanTM (Kit for the Preparation of Technetium Tc 99m Succimer Injection)
February 22, 2022Theragnostics Announces that its Radiotherapeutic for Treatment of Glioblastoma Multiforme has been Awarded UK’s MHRA Innovation Passport
February 10, 2022Theragnostics Announces Licensing Agreement for Development and Commercialization of One-Step PET Radiopharmaceuticals
September 22, 2021Theragnostics Strengthens Board of Directors with Key Appointments
August 4, 2021Theragnostics Announces a research collaboration with Essen University Hospital to study THG-008 for Oncology PET Imaging
February 17, 2021Developing radionuclide PARP inhibitors – MedNous Article
November 19, 2020Theragnostics Holding 1-2-1 Meetings at Jefferies 2020 Virtual London Healthcare Conference
November 10, 2020Summit Biomedical Imaging Signs Agreement with Theragnostics Enabling the Development of Novel Fluorescence-Based Cancer Diagnostics
September 9, 2020News Archive
